Aastrom Biosciences to acquire cell therapy and regenerative medicine business of Sanofi - MarketLine Financial Deals

Aastrom Biosciences to acquire cell therapy and regenerative medicine business of Sanofi

Aastrom Biosciences to acquire cell therapy and regenerative medicine business of Sanofi - MarketLine Financial Deals
Aastrom Biosciences to acquire cell therapy and regenerative medicine business of Sanofi
Published Apr 21, 2014
3 pages — Published Apr 21, 2014
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Aastrom Biosciences, Inc., a US-based biotechnology company, has entered into a definitive agreement to acquire Sanofi's cell therapy and regenerative medicine (CTRM) business

  
Source:
Document ID
MA146647_140422
Country
Country
Ticker
ASTM=US
Ticker
SAN=FR
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Aastrom Biosciences to acquire cell therapy and regenerative medicine business of Sanofi" Apr 21, 2014. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Aastrom-Biosciences-to-acquire-cell-therapy-and-regenerative-medicine-business-of-Sanofi-2052-102161>
  
APA:
MarketLine Financial Deals. (2014). Aastrom Biosciences to acquire cell therapy and regenerative medicine business of Sanofi Apr 21, 2014. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Aastrom-Biosciences-to-acquire-cell-therapy-and-regenerative-medicine-business-of-Sanofi-2052-102161>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.